Artwork

Content provided by Healio, Adam J. Brown, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healio, Adam J. Brown, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

ANCA Vasculitis and the Complement System, Part 1: The Mouse’s Tale

31:06
 
Share
 

Manage episode 407440404 series 3560282
Content provided by Healio, Adam J. Brown, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healio, Adam J. Brown, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This episode walks us through the initial research that paved the way for a game changing therapeutic in ANCA vasculitis, as well as the story of how host Adam J. Brown, MD, finally learned how to spell complement.

Brought to you by GSK. Considering a treatment change for patients with active SLE? Learn about a treatment option for your patients at treatfortodayandtomorrow.com.

  • Intro :10
  • Welcome :21
  • Today’s episode :24
  • So how did we get there? 4:18
  • How do we start teasing apart the effect of the complement in ANCA vasculitis? 8:13
  • Discussing and simplifying the mouse model 9:00
  • Quickly reviewing the complement cascade 12:06

Brought to you by GSK. Consider the long-term impact of disease activity flares and corticosteroid use on patients with active SLE. Learn more now at treatfortodayandtomorrow.com.

  • Taking the puzzle pieces away in the mouse model 17:04
  • What about the next steps? 22:05
  • What happens when you block C5a? 25:12
  • CCX168: Summing up the mouse tale 28:44
  • In the next episode 30:20
  • Thanks for listening 30:46

Disclosures: Brown reports no relevant financial disclosures.

We’d love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum

References:

Brilland B, et al. Autoimmun Rev. 2020;19:102424.

Freeley SJ, et al. J Pathol 2016;240:61-71.

Haas M, Eustace JA. Kidney Int 2004;65:2145-2152.

Huugen D, et al. Kidney Int 2007;71:646-654.

Marder SR, et al. Arg. J Immunol. 1985;134:3325-3331.

Schreiber A, et al. J Am Soc Nephrol. 2009;20:289-298.

Xiao H, et al. Am J Pathol. 2007;170:52-64.

Xiao H, et al. J Clin Invest 2002;110:955–963.

Xiao H, et al. J Am Soc Nephrol, 2014;25:225–231.

  continue reading

82 episodes

Artwork
iconShare
 
Manage episode 407440404 series 3560282
Content provided by Healio, Adam J. Brown, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healio, Adam J. Brown, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This episode walks us through the initial research that paved the way for a game changing therapeutic in ANCA vasculitis, as well as the story of how host Adam J. Brown, MD, finally learned how to spell complement.

Brought to you by GSK. Considering a treatment change for patients with active SLE? Learn about a treatment option for your patients at treatfortodayandtomorrow.com.

  • Intro :10
  • Welcome :21
  • Today’s episode :24
  • So how did we get there? 4:18
  • How do we start teasing apart the effect of the complement in ANCA vasculitis? 8:13
  • Discussing and simplifying the mouse model 9:00
  • Quickly reviewing the complement cascade 12:06

Brought to you by GSK. Consider the long-term impact of disease activity flares and corticosteroid use on patients with active SLE. Learn more now at treatfortodayandtomorrow.com.

  • Taking the puzzle pieces away in the mouse model 17:04
  • What about the next steps? 22:05
  • What happens when you block C5a? 25:12
  • CCX168: Summing up the mouse tale 28:44
  • In the next episode 30:20
  • Thanks for listening 30:46

Disclosures: Brown reports no relevant financial disclosures.

We’d love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum

References:

Brilland B, et al. Autoimmun Rev. 2020;19:102424.

Freeley SJ, et al. J Pathol 2016;240:61-71.

Haas M, Eustace JA. Kidney Int 2004;65:2145-2152.

Huugen D, et al. Kidney Int 2007;71:646-654.

Marder SR, et al. Arg. J Immunol. 1985;134:3325-3331.

Schreiber A, et al. J Am Soc Nephrol. 2009;20:289-298.

Xiao H, et al. Am J Pathol. 2007;170:52-64.

Xiao H, et al. J Clin Invest 2002;110:955–963.

Xiao H, et al. J Am Soc Nephrol, 2014;25:225–231.

  continue reading

82 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide